A method for simultaneously determining the content of tryptophan and kynurenine

Through HPLC-UV method and chromatographic analysis under specific conditions, the problem of simultaneous determination of tryptophan and kynurenine in rat cerebrospinal fluid was solved, and accurate and rapid detection was achieved, reducing costs and increasing detection limits were improved. Complex sample analysis of cerebrospinal fluid.

CN115236248BActive Publication Date: 2024-11-12SHANGHAI INST OF PHARMA IND CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110443928.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-04-23
Publication Date
2024-11-12
Estimated Expiration
2041-04-23

AI Technical Summary

Technical Problem

The prior art cannot accurately and simultaneously determine the content of tryptophan and kynurenine in rat cerebrospinal fluid, and the detection method is complex and costly, making it difficult to be applicable to a wide range of applications.

Method used

Using the HPLC-UV method, the Kromasil 100-5-C18 chromatography column was used, and the mobile phases were ammonium formate solution and methanol, and the ultraviolet detection wavelengths were 225nm and 279nm respectively. The samples were treated with ice methanol to remove impurities, so as to achieve tryptic ammonia in rat cerebrospinal fluid. Acid and kynurenine were measured simultaneously.

Benefits of technology

Accurate and rapid detection of tryptophan and kynurenine in rat cerebrospinal fluid is achieved, reducing detection costs, increasing detection limits, and simplifying the sample processing process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0003036169200000011
    Figure HDA0003036169200000011
  • Figure HDA0003036169200000012
    Figure HDA0003036169200000012
  • Figure HDA0003036169200000021
    Figure HDA0003036169200000021
Patent Text Reader

Abstract

The present invention discloses a method for simultaneously determining the content of tryptophan and kynurenine. The method uses an HPLC-UV instrument, and the sample measured is rat cerebrospinal fluid. The method includes the following conditions: chromatographic column: Kromasil 100-5-C18; mobile phase: aqueous phase is ammonium formate solution, and organic phase is methanol; ultraviolet light with a wavelength of 225nm is used to detect kynurenine, and ultraviolet light with a wavelength of 279nm is used to detect tryptophan. The method described in the present invention can realize the simultaneous determination of the content of tryptophan and kynurenine in rat cerebrospinal fluid, which is accurate, reliable, simple and easy to operate, and has excellent detection limit.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biochemistry, and in particular relates to a method for simultaneously determining the contents of tryptophan and kynurenine. Background Art

[0002] Tryptophan (TRP) is an essential amino acid for the human body. TRP taken into the body is mainly metabolized through the kynurenine metabolic pathway, among which kynurenine (KVN) is one of the most important intermediate metabolites in this metabolic pathway. Most metabolites produced under the kynurenine pathway are neuroactive, and these metabolites play an important role in regulating the function of N-methyl-D-aspartate (NMDA) receptors and the production of free radicals. The NMDA receptor is associated with a variety of neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, and depression. In addition, the production of free radicals and excitatory amino acids can also damage brain cells and aggravate brain damage in stroke states. Cerebrospinal fluid is a colorless and transparent liquid present in the ventricles and subarachnoid space, which contains a large number of brain tissue metabolites and can reflect the metabolic situation in the brain. Therefore, studying the content of tryptophan and kynurenine in rat cerebrospinal fluid is of great significance for the study of cardiovascular and cerebrovascular diseases and central nervous system diseases.

[0003] Since the molecular structure of kynurenine is relatively small, the fragments produced after proton impact using high performance liquid chromatography mass spectrometry (HPLC MS / MS) are also relatively small, which affects the selectivity and sensitivity of the detection. In addition, since the equipment is expensive and the detection cost is high, it is not suitable for widespread application.

[0004] Patent CN101776662A discloses a method for detecting kynurenine. The high performance liquid chromatography fluorescence method (HPLC-FLD) used therein must adopt an online derivatization method because kynurenine itself cannot produce fluorescence. This method is relatively complicated and has poor reproducibility.

[0005] The chromatographic conditions of the prior art are mainly aimed at the content of tryptophan or kynurenine in rat serum, brain tissue, and intestinal tissue. "High Performance Liquid Chromatography-UV Determination of Serum Kynurenine and Tryptophan and Its Clinical Application" (Wang Rui, 2006) reported a method for detecting kynurenine and tryptophan in serum using high performance liquid chromatography-ultraviolet detection (HPLC-UV). Since the Symmetry Shield C18 column has a long retention time for kynurenine, an alkaline substance, and the cerebrospinal fluid is complex and easily affected by impurities, it is impossible to simultaneously detect kynurenine and tryptophan in rat cerebrospinal fluid.

[0006] Cerebrospinal fluid is one of the inherent contents in the cranial cavity. It transports the metabolic products of brain tissue and regulates the acid-base balance of the central nervous system. Therefore, it contains metabolites and inflammatory exudates, especially more metabolites in the brain, which interferes more than blood samples. The main technical difficulty lies in the fact that cerebrospinal fluid contains a variety of brain metabolites. The small volume of cerebrospinal fluid causes a high concentration of metabolites and a large impact of impurities. The pH value is in dynamic change, which affects the pH of the sample. Conventional acid precipitation may not achieve the ideal effect, and existing analytical methods are difficult to accurately analyze. Serum is more stable than cerebrospinal fluid, the metabolite concentration is relatively low, and the composition is relatively stable. Conventional analytical methods can be used to handle it.

[0007] Since there is no report on the simultaneous determination of tryptophan or kynurenine content in rat cerebrospinal fluid in the prior art, there is an urgent need for an accurate and reliable detection method for the simultaneous detection of tryptophan and kynurenine content in cerebrospinal fluid to provide a scientific basis for related pathological and pharmaceutical research. Summary of the invention

[0008] In view of the technical defect that there is no method for simultaneously determining the content of kynurenine and tryptophan in rat cerebrospinal fluid in the prior art, the present invention provides a method for simultaneously determining the content of tryptophan and kynurenine. The method described in the present invention can realize the simultaneous determination of the content of tryptophan and kynurenine in rat cerebrospinal fluid, is accurate and reliable, simple and easy to operate, and has an excellent detection limit, which makes up for the shortcomings of the existing insufficient detection ability of the content of kynurenine and tryptophan in rat cerebrospinal fluid.

[0009] In order to overcome the above technical defects, the present invention provides a method for simultaneously determining the content of tryptophan and kynurenine, characterized in that the method uses an HPLC-UV instrument, the sample to be determined is rat cerebrospinal fluid, and the method includes the following conditions:

[0010] Column: Kromasil 100-5-C18;

[0011] Mobile phase: aqueous phase is ammonium formate solution, organic phase is methanol;

[0012] UV detection wavelength: 225nm for kynurenine and 279nm for tryptophan.

[0013] Preferably, the concentration of the ammonium formate solution is 3-8 mmol / L, preferably 5 mmol / L.

[0014] In the present invention, the HPLC-UV is high performance liquid chromatography-ultraviolet detection.

[0015] In the present invention, the chromatographic column Kromasil 100-5-C18 is produced by EKA Chemicals of Sweden.

[0016] In the present invention, the tryptophan and kynurenine are L-tryptophan and L-kynurenine respectively.

[0017] In a preferred embodiment, the volume ratio of the organic phase to the aqueous phase is 10:90-40:60, preferably 20:80.

[0018] Preferably, the column temperature of the chromatographic column is 30-50°C, preferably 45°C.

[0019] Preferably, the injection volume of the sample is 5-20 μl, preferably 10 μl.

[0020] Preferably, the flow rate of the sample is 0.5-3 mL / min, preferably 1.0 mL / min.

[0021] Preferably, the HPLC-UV instrument is an Ultimate 3000 high performance liquid chromatograph produced by Thermo-Dionex.

[0022] In a preferred embodiment, the conditions of the method are specifically:

[0023] Column: Kromasil 100-5-C18;

[0024] Mobile phase: the aqueous phase is 5mmol / L ammonium formate solution, the organic phase is methanol, and the volume ratio of the organic phase to the aqueous phase is 20:80;

[0025] The column temperature of the chromatographic column is 45°C;

[0026] The flow rate of the sample is 1.0 mL / min;

[0027] The injection volume of the sample is 10 μl;

[0028] UV detection wavelength: 225nm for kynurenine and 279nm for tryptophan;

[0029] The HPLC-UV instrument is an Ultimate 3000 high performance liquid chromatograph produced by Thermo-Dionex.

[0030] More preferably, the method further comprises preparing the sample according to the following steps before the detection: the rat cerebrospinal fluid is treated with ice methanol, and the supernatant is obtained to obtain the sample. Preferably, the rat cerebrospinal fluid and the ice methanol are mixed at a volume ratio of 1:3, and the impurities are precipitated to obtain the supernatant. More preferably, the mixing is vortexed for 30 seconds, and the precipitation is centrifuged at 13000 rpm for 8 minutes.

[0031] In a specific embodiment, the supernatant is filtered to obtain the sample.

[0032] On the basis of being in accordance with the common sense in the art, the above-mentioned preferred conditions can be arbitrarily combined to obtain the preferred embodiments of the present invention.

[0033] The reagents and raw materials used in the present invention are commercially available.

[0034] The positive and progressive effects of the present invention are:

[0035] The present invention provides a method for simultaneously determining the content of tryptophan and kynurenine, which can simultaneously and rapidly determine the content of tryptophan and kynurenine in rat cerebrospinal fluid, and the mobile phase uses less buffer salt, does not need to adjust the pH, and causes less damage to the instrument; the sample treatment is simple, the precipitant used is methanol, and the cost is low. The detection limit of the method of the present invention is improved, and the kynurenine is 0.003 μg / mL, and the tryptophan is 0.0125 μg / mL. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 is the kynurenine standard curve measured in Example 1;

[0037] Figure 2 The tryptophan standard curve measured in Example 1;

[0038] Figure 3 The tryptophan chromatogram measured in Example 1;

[0039] Figure 4 is the kynurenine chromatogram measured in Example 1;

[0040] Figure 5 This is the chromatogram of comparative example 1 for detecting rat cerebrospinal fluid samples. DETAILED DESCRIPTION

[0041] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The experimental methods in the following examples without specifying specific conditions are carried out according to conventional methods and conditions, or selected according to the product specifications.

[0042] Animals used: SD rats, 280-350 g, male, provided by Shanghai Slake Experimental Animal Co., Ltd., license number: SCXK (Shanghai) 2017-0005, SPF grade.

[0043] Instruments: Ultimate 3000 high performance liquid chromatograph (Thermo-Dionex); 5415R fully automatic high-speed refrigerated centrifuge (Eppendorf, Germany); MixMate vortex vortexer (Eppendorf, Germany); chromatographic column Kromasil 100-5-C18 purchased from EKA Chemicals, Sweden.

[0044] Example 1 Determination of Kynurenine and Tryptophan Contents in Rat Cerebrospinal Fluid

[0045] 1. Preparation of rat cerebrospinal fluid

[0046] The method is conventional in the art, and the specific method used in the present invention is as follows:

[0047] After anesthesia, the rats were subjected to direct puncture of the cerebellomedullary cisterna magna: the rats were fixed on a stereotaxic apparatus, a horizontal incision was made between the two ears of the rats, and then a vertical incision was made along the midline to the neck, the rhomboid muscles were bluntly peeled open, the inner half of the splenius muscle was cut off, and the splenius muscle end was pulled open with hemostatic forceps. Then a 1mL syringe was used to push from about 3mm below the occipital spine on the midline until there was a sense of empty space, and cerebrospinal fluid was slowly extracted. After about 100μl, the needle was withdrawn and the cerebrospinal fluid was transferred to a 1.5mL centrifuge tube and stored at -80℃.

[0048] 2. HPLC-UV detection method

[0049] Column: Kromasil 100-5-C18;

[0050] Mobile phase: aqueous phase is 5mmol / L ammonium formate solution, organic phase is methanol, volume percentage is methanol:5mmol / L ammonium formate = 20:80;

[0051] Flow rate: 1.0 mL / min;

[0052] Column temperature: 45°C;

[0053] Injection volume: 10 μl;

[0054] Ultraviolet detector (UV) wavelength: 225 nm for kynurenine and 279 nm for tryptophan.

[0055] 3. Preparation of standard curve

[0056] Accurately weigh appropriate amounts of L-kynurenine (purchased from Sigma Aldrich, batch number BCBX8788, purity 98%) and L-tryptophan (purchased from Sigma Aldrich, batch number WXBD954V, purity 98%).

[0057] After dissolving with methanol-water solution (methanol: water = 1:1), 1 mg / mL stock solutions of L-kynurenine and L-tryptophan were obtained, and then an appropriate amount of each stock solution was taken and diluted with methanol-water solution (methanol: water = 1:1) to prepare solutions with L-kynurenine concentrations of 0.1, 0.2, 0.4, 0.6, 1.2, 1.6, and 2.4 μg / mL and L-tryptophan concentrations of 1.25, 2.5, 5, 7.5, 15, 20, and 30 μg / mL.

[0058] The HPLC-UV method in step 2 yields

[0059] Standard curve of kynurenine (kyn): y = 8.943x + 0.2026, R 2 =0.999, such as Figure 1 As shown;

[0060] Standard curve of tryptophan (Trp): y = 0.1804x + 0.0262, R 2 =0.9993, such as Figure 2 shown.

[0061] 4. Sample processing

[0062] Accurately pipette 50 μl of rat cerebrospinal fluid into a centrifuge tube, add 150 μl of ice methanol for precipitation (i.e., the volume ratio of rat cerebrospinal fluid to ice methanol is 1:3), vortex for 30 seconds, centrifuge at 13000 rpm for 8 minutes, filter the supernatant, and take 100 μl of the filtered supernatant for injection detection. The detection method is as shown in the HPLC-UV method in step 2. The whole process was protected from light. The two UV detection channels of the Ultimate 3000 high performance liquid chromatograph were used to detect tryptophan and kynurenine in the sample at set wavelengths to obtain the chromatograms of tryptophan and kynurenine, see Figure 3 and Figure 4 .

[0063] 5. Result calculation

[0064] The absorbance of tryptophan was measured to be 0.650, the peak time was 5.640 min, and the concentration was calculated to be 3.459 μg / mL according to the standard curve;

[0065] The absorbance value of kynurenine was measured to be 2.679, the peak time was 5.627 min, and the concentration was calculated to be 0.277 μg / mL based on the standard curve.

[0066] 6. Detection limit

[0067] In this embodiment, the limit of quantification is 0.1 μg / mL for kynurenine and 1.25 μg / mL for tryptophan. The signal-to-noise ratio measured at the lower limit of quantification of kynurenine is 33, and the signal-to-noise ratio measured at the lower limit of quantification of tryptophan is 100. The detection limit is calculated based on the signal-to-noise ratio of 3, and the kynurenine is 0.003 μg / mL, and the tryptophan is 0.0125 μg / mL.

[0068] Comparative Example 1: Detection of kynurenine and tryptophan content in rat cerebrospinal fluid by existing HPLC-UV method

[0069] The preparation of rat cerebrospinal fluid was the same as in Example 1, and the sample processing and detection methods were based on "High Performance Liquid Chromatography-UV Determination of Serum Kynurenine and Tryptophan and Its Clinical Application" (Wang Rui, 2006).

[0070] After taking out the cerebrospinal fluid sample from the refrigerator, thaw it at room temperature, take 200 μl of the cerebrospinal fluid sample and place it in a centrifuge tube, add an equal amount of 5% (v / v) perchloric acid solution, vortex mix for 30 seconds, leave it at room temperature for 10-15 minutes, then centrifuge it at 10000r / min for 5 minutes, and take the supernatant for analysis.

[0071] Chromatographic conditions:

[0072] Column: Kromasil 100-5-C18;

[0073] Mobile phase: 15mmol / L sodium acetate-acetic acid containing acetonitrile (containing 2.7% acetonitrile, pH 3.6)

[0074] Flow rate: 1.0 mL / min;

[0075] Injection volume: 20 μl;

[0076] Column temperature: room temperature;

[0077] Ultraviolet detector (UV) wavelength: 225nm.

[0078] Results: Kynurenine or tryptophan could not be detected using the comparative method. Figure 5 , it is impossible to simultaneously detect the contents of kynurenine and tryptophan in rat cerebrospinal fluid.

Claims

1. A method for simultaneously determining the content of tryptophan and kynurenine, characterized in that: The method uses an HPLC-UV instrument, the sample measured is rat cerebrospinal fluid, and the method includes the following conditions: Column: Kromasil 100-5-C18; Mobile phase: the aqueous phase is 5mmol / L ammonium formate solution, the organic phase is methanol, and the volume ratio of the organic phase to the aqueous phase is 20:80; The column temperature of the chromatographic column is 45°C; The flow rate of the sample is 1.0 mL / min; The injection volume of the sample is 10 μl; UV detection wavelength: 225nm for kynurenine and 279nm for tryptophan; The HPLC-UV instrument is an Ultimate 3000 high performance liquid chromatograph produced by Thermo-Dionex; The method further comprises preparing the sample according to the following steps before the detection: the rat cerebrospinal fluid is mixed with ice methanol at a volume ratio of 1:3, and then impurities are precipitated to obtain a supernatant to obtain the sample.

2. The method according to claim 1, characterized in that The mixing was performed by vortexing for 30 seconds, and the precipitation was performed by centrifugation at 13000 rpm for 8 minutes.

3. The method according to claim 2, characterized in that The supernatant is filtered to obtain the sample.